{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:59:51Z","timestamp":1765807191354},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,8,15]],"date-time":"2014-08-15T00:00:00Z","timestamp":1408060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s00430-014-0352-3","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T01:27:54Z","timestamp":1407979674000},"page":"177-183","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High seroprevalence of human herpesvirus type 8 infection in males with advanced lung carcinoma"],"prefix":"10.1007","volume":"204","author":[{"given":"Cheng-Chuan","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Liang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ming","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang-Yuan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,15]]},"reference":[{"key":"352_CR1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jcp.2004.023622","volume":"58","author":"CC Su","year":"2005","unstructured":"Su CC, Li CF, Liao YL, Lin CN, Lu JJ (2005) Immunohistochemical and molecular assessment of human herpesvirus type 8 in gastrointestinal tumors. J Clin Pathol 58:856\u2013859","journal-title":"J Clin Pathol"},{"key":"352_CR2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.transproceed.2003.11.040","volume":"36","author":"AA Al-Khader","year":"2004","unstructured":"Al-Khader AA, Shaheen FA (2004) Posttransplant complications encountered in renal transplantation in the Middle East. Transplant Proc 36:180\u2013183","journal-title":"Transplant Proc"},{"key":"352_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0190-9622(98)70501-8","volume":"38","author":"PL Rady","year":"1998","unstructured":"Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, David M, Hudnall SD, Tyring SK (1998) Detection of human herpesvirus-8 DNA in Kaposi\u2019s sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol 38:429\u2013437","journal-title":"J Am Acad Dermatol"},{"key":"352_CR4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1086\/315742","volume":"182","author":"C Fiuza","year":"2000","unstructured":"Fiuza C, Salcedo M, Clemente G, Tellado JM (2000) In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis 182:526\u2013533","journal-title":"J Infect Dis"},{"key":"352_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02592558","volume":"25","author":"L Lombardo","year":"1995","unstructured":"Lombardo L, Capaldi A, Poccardi G, Vineis P (1995) Peripheral blood CD3 and CD4 T-lymphocyte reduction correlates with severity of liver cirrhosis. Int J Clin Lab Res 25:153\u2013156","journal-title":"Int J Clin Lab Res"},{"key":"352_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.1840040109","volume":"4","author":"A Rimola","year":"1984","unstructured":"Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J (1984) Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 4:53\u201358","journal-title":"Hepatology"},{"key":"352_CR7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1309\/4FMBN316N4792UQ4","volume":"130","author":"AL Chou","year":"2008","unstructured":"Chou AL, Huang WW, Tsao SM, Li CT, Su CC (2008) Human herpesvirus type 8 in patients with cirrhosis: correlation with sex, alcoholism, hepatitis B virus, disease severity, and thrombocytopenia. Am J Clin Pathol 130:231\u2013237","journal-title":"Am J Clin Pathol"},{"key":"352_CR8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jcp.2009.071621","volume":"63","author":"AL Chou","year":"2010","unstructured":"Chou AL, Huang WW, Lin MN, Su CC (2010) Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia. J Clin Pathol 63:254\u2013258","journal-title":"J Clin Pathol"},{"key":"352_CR9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000029397","volume":"66","author":"J Cadranel","year":"1999","unstructured":"Cadranel J, Naccache J, Wislez M, Mayaud C (1999) Pulmonary malignancies in the immunocompromised patient. Respiration 66:289\u2013309","journal-title":"Respiration"},{"issue":"Suppl 2","key":"352_CR10","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0169-5002(01)00348-8","volume":"34","author":"E Pluygers","year":"2001","unstructured":"Pluygers E, Sadowska A, Chyczewski L, Niklinski J, Niklinska W, Chyczewska E (2001) The impact of immune responses on lung cancer and the development of new treatment modalities. Lung Cancer 34(Suppl 2):S71\u2013S77","journal-title":"Lung Cancer"},{"key":"352_CR11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1200\/JCO.1996.14.4.1071","volume":"14","author":"B Reckzeh","year":"1996","unstructured":"Reckzeh B, Merte H, Pfluger KH, Pfab R, Wolf M, Havemann K (1996) Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small-cell lung cancer. J Clin Oncol 14:1071\u20131076","journal-title":"J Clin Oncol"},{"key":"352_CR12","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1200\/JCO.1999.17.12.3822","volume":"17","author":"E Fokkema","year":"1999","unstructured":"Fokkema E, Groen HJ, Bauer J, Uges DR, Weil C, Smith IE (1999) Phase II study of oral platinum drug JM216 as first-line treatment in patients with small-cell lung cancer. J Clin Oncol 17:3822\u20133827","journal-title":"J Clin Oncol"},{"key":"352_CR13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0360-3016(98)00370-8","volume":"43","author":"MI Koukourakis","year":"1999","unstructured":"Koukourakis MI, Giatromanolaki A, Schiza S, Kakolyris S, Georgoulias V (1999) Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation. Int J Radiat Oncol 43:107\u2013114","journal-title":"Int J Radiat Oncol"},{"issue":"2 Suppl 1","key":"352_CR14","first-page":"136","volume":"9","author":"F Robert","year":"1999","unstructured":"Robert F, Childs HA, Spencer SA, Redden DT, Hawkins MM (1999) Phase I\/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity. Semin Radiat Oncol 9(2 Suppl 1):136\u2013147","journal-title":"Semin Radiat Oncol"},{"key":"352_CR15","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3656-4","volume-title":"American joint committee on cancer (AJCC): cancer staging manual","author":"FL Greene","year":"2002","unstructured":"Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) American joint committee on cancer (AJCC): cancer staging manual, 6th edn. Springer, New York","edition":"6"},{"key":"352_CR16","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(80)90284-6","volume":"2","author":"SJ O\u2019Keefe","year":"1980","unstructured":"O\u2019Keefe SJ, El-Zayadi AR, Carraher TE, Davis M (1980) Malnutrition and immuno-incompetence in patients with liver disease. Lancet 2:615\u2013617","journal-title":"Lancet"},{"key":"352_CR17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/jinf.2000.0639","volume":"40","author":"A Muller","year":"2000","unstructured":"Muller A, Franzen C, Klussmann P, Wagner M, Diehl V, Fatkenheuer G, Salzberger B, Ablashi DV, Krueger GR (2000) Human herpesvirus type 8 in HIV-infected patients with interstitial pneumonitis. J Infect 40:242\u2013247","journal-title":"J Infect"},{"key":"352_CR18","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/00002030-199907090-00004","volume":"13","author":"PM Cook","year":"1999","unstructured":"Cook PM, Whitby D, Calabro ML, Luppi M, Kakoola DN, Hjalgrim H, Ariyoshi K, Ensoli B, Davison AJ, Schulz TF (1999) Variability and evolution of Kaposi\u2019s sarcoma-associated herpesvirus in Europe and Africa, the International Collaborative Group. AIDS 13:1165\u20131176","journal-title":"AIDS"},{"issue":"Pt 3","key":"352_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1099\/0022-1317-82-3-499","volume":"82","author":"YX Meng","year":"2001","unstructured":"Meng YX, Sata T, Stamey FR, Voevodin A, Katano H, Koizumi H, Deleon M, De Cristofano MA, Galimberti R, Pellett PE (2001) Molecular characterization of strains of Human herpesvirus 8 from Japan, Argentina and Kuwait. J Gen Virol 82(Pt 3):499\u2013506","journal-title":"J Gen Virol"},{"key":"352_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcv.2013.06.005","volume":"58","author":"CC Su","year":"2013","unstructured":"Su CC, Tsai JP, Lin MN, Hsieh TC, Tseng RC, Chu TY (2013) High seroprevalence of human herpesvirus type 8 in patients with end-stage renal disease in Taiwan. J Clin Virol 58:89\u201393","journal-title":"J Clin Virol"},{"key":"352_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0169-5002(98)00024-5","volume":"20","author":"A Masotti","year":"1998","unstructured":"Masotti A, Morandini G, Ortolani R, Fumagalli L (1998) Phase-II randomized study of pre-operative IL-2 administration in operable NSCLC. Lung Cancer 20:191\u2013202","journal-title":"Lung Cancer"},{"key":"352_CR22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00430-011-0187-0","volume":"200","author":"C Reinheimer","year":"2011","unstructured":"Reinheimer C, Allwinn R, Sturmer M (2011) Do fewer cases of Kaposi\u2019s sarcoma in HIV-infected patients reflect a decrease in HHV8 seroprevalence? Med Microbiol Immun 200:161\u2013164","journal-title":"Med Microbiol Immun"},{"key":"352_CR23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-8981(02)00023-2","volume":"320","author":"YF Wang","year":"2002","unstructured":"Wang YF, Lee SB, Cheng LC, Tai MH, Su IJ (2002) Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan. Clin Chim Acta 320:37\u201342","journal-title":"Clin Chim Acta"},{"key":"352_CR24","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bjc.6602409","volume":"92","author":"L Brouchet","year":"2005","unstructured":"Brouchet L, Valmary S, Dahan M, Didier A, Galateau-Salle F, Brousset P, Degano B (2005) Detection of oncogenic virus genomes and gene products in lung carcinoma. Br J Cancer 92:743\u2013746","journal-title":"Br J Cancer"},{"key":"352_CR25","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1086\/432103","volume":"192","author":"T Woodberry","year":"2005","unstructured":"Woodberry T, Suscovich TJ, Henry LM, Martin JN, Dollard S, O\u2019Connor PG, Davis JK, Osmond D, Lee TH, Kedes DH, Khatri A, Lee J, Walker BD, Scadden DT, Brander C (2005) Impact of Kaposi sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins. J Infect Dis 192:622\u2013629","journal-title":"J Infect Dis"},{"key":"352_CR26","first-page":"144","volume":"3","author":"K Azadmanesh","year":"2012","unstructured":"Azadmanesh K, Norouzfar ZS, Sohrabi A, Safaie-Naraghi Z, Moradi A, Yaghmaei P, Naraghi MM, Arashkia A, Eslamifar A (2012) Characterization of human herpes virus 8 genotypes in Kaposi\u2019s sarcoma patients in Tehran, Iran. Int J Mol Epidemiol Genet 3:144\u2013152","journal-title":"Int J Mol Epidemiol Genet"},{"key":"352_CR27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jcv.2011.12.016","volume":"53","author":"O Cassar","year":"2012","unstructured":"Cassar O, Charavay F, Bassot S, Plancoulaine S, Grangeon JP, Laumond-Barny S, Martin PM, Chanteau S, Gessain A (2012) Divergent KSHV\/HHV-8 subtype D strains in New Caledonia and Solomon Islands, Melanesia. J Clin Virol 53:214\u2013218","journal-title":"J Clin Virol"},{"key":"352_CR28","first-page":"129","volume":"41","author":"L Vuckovic-Dekic","year":"1999","unstructured":"Vuckovic-Dekic L, Susnjar S, Stanojevic-Bakic N, Radosavljevic D (1999) Radio- and chemotherapy variably affect the general immunocompetence of lung cancer patients. Panminerva Med 41:129\u2013133","journal-title":"Panminerva Med"},{"key":"352_CR29","first-page":"3863","volume":"50","author":"T Okabe","year":"1990","unstructured":"Okabe T, Yasukawa K (1990) A human monocyte growth factor produced by lung cancer cells. Cancer Res 50:3863\u20133865","journal-title":"Cancer Res"},{"key":"352_CR30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.1997.03540300046032","volume":"277","author":"DH Kedes","year":"1997","unstructured":"Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R (1997) The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. JAMA 277:478\u2013481","journal-title":"JAMA"},{"key":"352_CR31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0929-6646(09)60337-5","volume":"105","author":"CC Su","year":"2006","unstructured":"Su CC, Lu JJ, Perng CL, Yu FT, Chiu CH (2006) Evolution of human herpesvirus type 8-associated gastric Kaposi\u2019s sarcoma following corticosteroid treatment for asthma. J Formos Med Assoc 105:155\u2013159","journal-title":"J Formos Med Assoc"},{"key":"352_CR32","first-page":"2826","volume":"90","author":"C Parravicini","year":"1997","unstructured":"Parravicini C, Olsen SJ, Capra M, Poli F, Sirchia G, Gao SJ, Berti E, Nocera A, Rossi E, Bestetti G, Pizzuto M, Galli M, Moroni M, Moore PS, Corbellino M (1997) Risk of Kaposi\u2019s sarcoma-associated herpes virus transmission from donor allografts among Italian posttransplant Kaposi\u2019s sarcoma patients. Blood 90:2826\u20132829","journal-title":"Blood"},{"key":"352_CR33","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","volume":"9","author":"C Frances","year":"2009","unstructured":"Frances C, Marcelin AG, Legendre CH, Chevret S, Dussaix E, Lejeune J, Euvrard S, Bigorie A, Schulz TF, Agbalika F, Lebbe C (2009) Skin and Organ Transplantation Group of the French Society of Dermatology. The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival. Am J Transplant 9:2580\u20132586","journal-title":"Am J Transplant"},{"key":"352_CR34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/598523","volume":"199","author":"S Sanjose de","year":"2009","unstructured":"de Sanjose S, Mbisa G, Perez-Alvarez S, Benavente Y, Sukvirach S, Hieu NT, Shin HR, Anh PT, Thomas J, Lazcano E, Matos E, Herrero R, Munoz N, Molano M, Franceschi S, Whitby D (2009) Geographic variation in the prevalence of Kaposi sarcoma-associated herpesvirus and risk factors for transmission. J Infect Dis 199:1449\u20131456","journal-title":"J Infect Dis"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0352-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-014-0352-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-014-0352-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T18:20:56Z","timestamp":1565720456000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-014-0352-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,15]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1007\/s00430-014-0352-3","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,15]]}}}